Specialists for Primary mediastinal large B-cell lymphoma

34 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Matthew Frigault, MD
Rare Disease Specialist
Massachusetts General Hospital
Boston, Massachusetts
QC-verified PI×2
Amrita Desai
Rare Disease / Clinical Research
OHSU Knight Cancer Institute
QC-verified PI×1
Chirayu Patel, MD, MD, MPH
Rare Disease / Clinical Research
Massachusetts General Hospital
BOSTON, MA
QC-verified PI×1
Alex F Herrera
Rare Disease / Clinical Research
City of Hope Medical Center
PI×7
Mitchell Cairo, MD, MD
Rare Disease / Clinical Research
New York Medical College
HAWTHORNE, NY
PI×11
Ajay Gopal
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×14
Mengyang Di, MD, PhD, MD
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×2
Jae Park, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×14
Study Official
Rare Disease / Clinical Research
Genmab
PI×10
François-Xavier GROS, Prof. Dr.
Rare Disease / Clinical Research
University Hospital, Bordeaux
PI×1
Frederick Locke, MD, M.D
Rare Disease / Clinical Research
Moffitt Cancer Center
TAMPA, FL
PI×1
Catherine THIEBLEMONT, Prof. Dr.
Rare Disease / Clinical Research
Hôpital Saint-Louis
PI×1
Jennifer Crombie, MD, M.D
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
BOSTON, MA
PI×3
Gabriel BRISOU, Prof. Dr.
Rare Disease / Clinical Research
Institut Paoli-Calmettes
PI×1
Thomas E. Witzig, MD, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
PI×9
Sarah Larson, MD
Rare Disease / Clinical Research
UCLA / Jonsson Comprehensive Cancer Center
PI×1
Pytlik Robert, M.D.
Rare Disease / Clinical Research
1st Department of Medicine, General University Hospital, Prague
PI×1
Nirav Shah, MD
Rare Disease / Clinical Research
Medical College of Wisconsin
PI×6
Nathan Denlinger, DO, MS, D.O
Rare Disease / Clinical Research
Ohio State University Comprehensive Cancer Center
COLUMBUS, OH
PI×1
Marek Trněný, M.D., PhD.
Rare Disease / Clinical Research
General University Hospital, Prague
PI×1
Kevin Hay, MD
Rare Disease / Clinical Research
BC Cancer
EL PASO, TX
PI×1
Alexandre Hirayama
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
PI×1 8
Yuankai Shi, MD
Rare Disease / Clinical Research
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PI×14
Veronika Bachanova, MD, PhD, MD
Rare Disease / Clinical Research
University of Minnesota
MINNEAPOLIS, MN
PI×2
Yi Lin, MD, PhD
Rare Disease / Clinical Research
Mayo Clinic
PI×1
Chet Bohac, PharmD, MD, MSc
Rare Disease / Clinical Research
Executive Medical Director, Clinical Development, Xencor, Inc.
PI×1
C. Babis Andreadis, MD
Rare Disease / Clinical Research
University of California, San Francisco
PI×1
Djordje Atanackovic, M.D
Professor of Medicine
BALTIMORE, MD
QC-verified PI×1
Jakub Svoboda, MD
University of Pennsylvania
PHILADELPHIA, PA
QC-verified PI×4
Lisa G Roth
Children's Oncology Group
QC-verified PI×1
Nabila N Bennani, M.D
Mayo Clinic Cancer Center LAO
ROCHESTER, MN
QC-verified PI×2
Vincent CAMUS
Centre Henri Becquerel
QC-verified PI×4
Ugo Consoli
U.O.C Ematologia, ARNAS Garibaldi; P.O. Garibaldi - Nesima, Catania.
QC-verified PI×1
Maryam Rahman
Rare Disease / Clinical Research
University of Florida
PI×1

More about Primary mediastinal large B-cell lymphoma